Texas A&M University's latest breakthrough in neuroscience has pinpointed a rare group of neurons capable of bridging damaged spinal circuits, potentially reigniting leg movement in individuals paralyzed by spinal cord injury (SCI). Led by Assistant Professor Jennifer N. Dulin from the Department of Biology, this research illuminates how transplanted neural progenitor cells (NPCs) can integrate into the body's motor networks, offering hope for more targeted regenerative therapies.

Spinal cord injuries disrupt the vital communication pathway between the brain and lower body, leaving approximately 18,000 Americans newly affected each year and over 300,000 living with paralysis. At Texas A&M, scientists are unraveling the cellular mechanisms behind recovery, shifting from broad stem cell transplants to precision neuron engineering.

Understanding Spinal Cord Injuries and the Quest for Recovery

Spinal cord injury occurs when trauma severs or compresses the spinal cord, halting neural signals. Thoracic injuries, like those modeled in this study at the T12 level, often result in paraplegia, impairing leg function while sparing upper body control. Traditional treatments focus on stabilization and rehabilitation, but no FDA-approved therapy restores lost connections—until now, with insights from university labs like Texas A&M's.

In the U.S., SCI prevalence stands at about 54 cases per million annually, with incomplete injuries (47.4% tetraplegia, 20% paraplegia) offering partial recovery potential through neuroplasticity—the brain and spinal cord's ability to rewire. Texas A&M researchers are pioneering how specific interneurons can exploit this plasticity post-injury.

Texas A&M's Innovative Methodology: From Transplant to Activation

The study utilized a mouse model of thoracic contusion SCI, mimicking human trauma with an Infinite Horizons Impactor delivering 60 kdynes force at T12. One week post-injury, researchers transplanted syngeneic NPCs derived from embryonic day 12.5 (E12.5) mouse spinal cords. These multipotent cells differentiated into graft-derived neurons (GDNs), including excitatory glutamatergic V2a interneurons (marked by Chx10 expression) and cholinergic neurons (ChAT+).

• NPCs suspended in fibrin matrix (contusion) or HBSS (dorsal column lesion), injected at multiple depths.
• Transsynaptic tracing with rabies virus (RABV) from ChAT-cre motor neurons and pseudorabies virus (PRV) from sciatic nerve to map connections.
• Chemogenetic tools: Cre-dependent hM3Dq DREADDs (Syn1-cre for all GDNs, ChAT-cre for cholinergic, Chx10-cre for V2a) activated by clozapine-N-oxide (CNO, 5 mg/kg i.p.).
• Electromyography (EMG) on six hindlimb muscles; behavioral assays like Basso Mouse Scale and MoSeq for locomotion.

This rigorous approach revealed GDNs' synaptic integration, though sparse, sufficient to modulate motor output in responders.

Groundbreaking Findings: V2a Interneurons Drive Locomotion Signals

Key discovery: GDNs formed functional synapses with host hindlimb motor circuitry. RABV tracing showed low monosynaptic connectivity (~1.59 infectivity index to motor neurons), but polysynaptic links via PRV (~6.39 index). V2a GDNs exhibited distinct axonal projections, targeting lumbar motor pools essential for stepping.

CNO activation triggered robust EMG responses in 20-30% of animals—hundreds of spikes/min in muscles like lateral gastrocnemius and tibialis anterior, exceeding baseline (<10 spikes/min). Responders displayed altered gait motifs in MoSeq, hinting at circuit modulation. Cholinergic and V2a subtypes showed targeted terminations, underscoring their role in locomotion.

However, no overall locomotor improvement without activation, emphasizing connectivity limits. Graft volume inversely correlated with integration density, suggesting optimization needs.

Spotlight on Jennifer N. Dulin: Leading Texas A&M's Neuroscience Charge

Jennifer N. Dulin, Ph.D., heads this work at Texas A&M's Department of Biology and Texas A&M Institute for Neuroscience (TAMIN). Her lab deciphers graft-host interactions, building on prior studies like sex-mismatched NPC effects and developmental stage impacts. Dulin likens SCI to a broken circuit: "We're placing new cells to reconnect pathways." Her vision: enrich transplants for V2a-like neurons, pair with rehab for mature integration.

Undergrads and grads in her lab gain hands-on experience in electrophysiology, tracing, and behavior, fostering the next generation of neuroscientists at Texas A&M.

Implications for Stem Cell Therapies in Higher Education Research

This advances NPC transplantation, promising since 2010s trials showed modest gains. By identifying V2a interneurons—excitatory cells rhythmically firing during locomotion—Texas A&M paves targeted enrichment via CRISPR or sorting.Full study in Nature Communications highlights chemogenetics' proof-of-concept for circuit repair.

Universities like Texas A&M drive this, with TAMIN funding interdisciplinary work. Challenges: low integration (under 5% polysynaptic), immaturity needing rehab. Future: human iPSC-derived V2a neurons for trials.

Broader Context: SCI Landscape and University Contributions

Source: NSCISC/Reeve Foundation.

Texas A&M joins leaders like EPFL (V2a stimulation) and UAB (NSCISC stats), emphasizing academia's role in translation.

Challenges in SCI Recovery and Texas A&M's Path Forward

• Sparse Connectivity: Only 20-30% responders; optimize graft density/composition.
• Maturation: GDNs need activity-based therapy, akin to infant motor learning.
• Scalability: Mouse to human; iPSCs key.

Dulin's team eyes subtype enrichment, rehab protocols. TAMU's resources position it centrally in regenerative medicine.

Impact on Neuroscience Careers and Higher Education

This study exemplifies opportunities at research universities. Texas A&M trains students in cutting-edge techniques, preparing for roles in biotech, academia. Fields like neural engineering boom, with demand for PhDs in stem cell neurobiology.

Explore faculty positions or postdocs via university job boards.

Photo by Centre for Ageing Better on Unsplash

Future Outlook: From Lab to Clinic

Texas A&M's work heralds refined therapies, potentially restoring walking. Combined with exoskeletons or stimulation, full recovery edges closer. Universities remain pivotal, turning basic science into hope.